773.282.9845
3401 N. Central Avenue Chicago, IL 60634

MEMORY STUDY #1

MEMORY #1

RESEARCH STUDY

What is this study investigating:

This study is exploring an injectable investigational medication for the treatment of mild Alzheimer’s Disease.

Why is this study being conducted:

There is a significant need for those suffering from Alzheimer’s Disease to find a treatment that is efficacious in helping them.

Logistics:

  • 104 weeks in duration with option for additional follow up study
  • 46 doses every 1 month for 6 months and then every 2 weeks thereafter

You may qualify if:

  • You are ages 50 to 90 years old
  • You are currently suffering from mild Alzheimer’s disease
Contact Us